Watchlist

Watchlist
Merrimack Pharmaceuticals, Inc. (MACK)
Merrimack Pharmaceuticals, Inc. (MACK)
Merrimack Secures $25 Million Debt Facility with Hercules Capital
CAMBRIDGE, Mass. , July 2, 2018 /PRNewswire/ --Merrimack Pharmaceuticals, Inc.(Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced the closing of a $25 million term loan with Hercules Capital (NYSE: HTGC), $15 million of w…
Merrimack Pharmaceuticals, Inc. (MACK)
Merrimack Pharmaceuticals, Inc. (MACK)